Dr. Bashar Karmi

Dr. Bashar Karmi

Bashar Adnan Karmi. Date of birth: 29/5/1960 Tulkarm- Palestine, married with five children.

Physician / Clinical Pathologist, MD -. USSR 1985

                Residency at Jordan University Hospital 1987- 1991

                Jordanian Board in clinical pathology 1991

                MSC. Clinical Pathology Medical Microbiology & Clinical Immunology –Jordan University 1991

Professional Experience

  • 1986-87 private clinic.
  • 1987-1991 Residency at Jordan University Hospital –Pathology Department.
  • 1991-1998 Head of Laboratory Services and Blood Banking in West Bank and thereafter in Palestinian Ministry of Health.
  • 1996-1998- Head of Ramallah Laboratory in Medicare Co.
  • 1998- 2017 Medicare General Manager & Medicare Board Vice Chairman.
  • 2018- Now Medicare Board Chairman and Medicare CEO.

Membership- member of Jordan Medical Association since 1986.

Founder and Board member of Palestinian Thalassemia Patient’s Friends Society- 1996.

 

Languages: Arabic, English, Russian, Hebrow.

Teaching experience- part time in Al Quds University 1992-2000

                                 - Part time in Ber Zeit University 2000-200

Published articles:-

 

  • Assessment of gonadal and thyroid function for adult transfusion dependent Beta thalassemia patients in Palestine

          Kamal Dumaidi, Amer AlJawabreh, Bashar Karmi- 2015.

 

  • Factors associated with continuing emergence of Beta thalassemia major despite prenatal testing: a cross- sectional survey

 

     Haleama Al Sabbah,1 Sarah Khan,1 Abdallah Hamadna,2 Lamia Abu GhazalehBashar Karmi

 

  • Quality of life of Thalassemia Patients in the West Bank of Palestine,

Pamela Kohlbry PhD, RN, Bashar Karmi, MD, BSC, Robert C. Yamashita PhD.

 

4) Quality of Life of Thalassemia Patients Living in the West Bank and Gaza  2022                        

- new look and evaluation                          

 

Unpublished studies:-

 

  • “Rubella immune status of Palestinian women. A study for more than 800 ladies tested for Rubella IgG in the period of 2002 and 2017.
  • Detection of drug abuse overview- Study of Medicare laboratory results 2005-2010.
  • The facts considering blood plasma “converted- halal” substance from scientific point of view. Kuwait 2014, Third Gulf Halal Conference.
  • The status of Vitamin B12 among Palestinian population, study between 2001-2015 years in Medicare results.